Outlook Therapeutics Inc. (NASDAQ: OTLK)
$9.23
+0.7800 ( +9.23% ) 262.8K
Outlook Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing ONS-5010, a monoclonal antibody, or mAb, for various ophthalmic indications.
Market Data
Open
$9.23
Previous close
$8.45
Volume
262.8K
Market cap
$215.80M
Day range
$8.46 - $9.24
52 week range
$4.00 - $37.00
SEC Fillings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| 8-k | 8K-related | 16 | Apr 12, 2024 |
| 8-k | 8K-related | 13 | Apr 02, 2024 |
| 4 | Insider transactions | 1 | Mar 29, 2024 |
| 8-k | 8K-related | 13 | Mar 26, 2024 |
| 4 | Insider transactions | 1 | Mar 22, 2024 |
| 4 | Insider transactions | 1 | Mar 22, 2024 |
| 4 | Insider transactions | 1 | Mar 22, 2024 |
| 4 | Insider transactions | 1 | Mar 20, 2024 |
| 8-k | 8K-related | 14 | Mar 18, 2024 |
| 4 | Insider transactions | 1 | Mar 11, 2024 |